BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23534552)

  • 1. Launching spiking ligands into a protein-protein interface: a promising strategy to destabilize and break interface formation in a tRNA modifying enzyme.
    Immekus F; Barandun LJ; Betz M; Debaene F; Petiot S; Sanglier-Cianferani S; Reuter K; Diederich F; Klebe G
    ACS Chem Biol; 2013; 8(6):1163-78. PubMed ID: 23534552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Glues a Homodimer Together: Systematic Analysis of the Stabilizing Effect of an Aromatic Hot Spot in the Protein-Protein Interface of the tRNA-Modifying Enzyme Tgt.
    Jakobi S; Nguyen PT; Debaene F; Cianférani S; Reuter K; Klebe G
    ACS Chem Biol; 2015 Aug; 10(8):1897-907. PubMed ID: 25951081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soaking suggests "alternative facts": Only co-crystallization discloses major ligand-induced interface rearrangements of a homodimeric tRNA-binding protein indicating a novel mode-of-inhibition.
    Ehrmann FR; Stojko J; Metz A; Debaene F; Barandun LJ; Heine A; Diederich F; Cianférani S; Reuter K; Klebe G
    PLoS One; 2017; 12(4):e0175723. PubMed ID: 28419165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative approach combining noncovalent mass spectrometry, enzyme kinetics and X-ray crystallography to decipher Tgt protein-protein and protein-RNA interaction.
    Ritschel T; Atmanene C; Reuter K; Van Dorsselaer A; Sanglier-Cianferani S; Klebe G
    J Mol Biol; 2009 Nov; 393(4):833-47. PubMed ID: 19627989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding.
    Stengl B; Meyer EA; Heine A; Brenk R; Diederich F; Klebe G
    J Mol Biol; 2007 Jul; 370(3):492-511. PubMed ID: 17524419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot-spot analysis to dissect the functional protein-protein interface of a tRNA-modifying enzyme.
    Jakobi S; Nguyen TX; Debaene F; Metz A; Sanglier-Cianférani S; Reuter K; Klebe G
    Proteins; 2014 Oct; 82(10):2713-32. PubMed ID: 24975703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting a Cryptic Pocket in a Protein-Protein Contact by Disulfide-Induced Rupture of a Homodimeric Interface.
    Nguyen D; Xie X; Jakobi S; Terwesten F; Metz A; Nguyen TXP; Palchykov VA; Heine A; Reuter K; Klebe G
    ACS Chem Biol; 2021 Jun; 16(6):1090-1098. PubMed ID: 34081441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Importance of Charge in Perturbing the Aromatic Glue Stabilizing the Protein-Protein Interface of Homodimeric tRNA-Guanine Transglycosylase.
    Nguyen A; Nguyen D; Phong Nguyen TX; Sebastiani M; Dörr S; Hernandez-Alba O; Debaene F; Cianférani S; Heine A; Klebe G; Reuter K
    ACS Chem Biol; 2020 Nov; 15(11):3021-3029. PubMed ID: 33166460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From lin-benzoguanines to lin-benzohypoxanthines as ligands for Zymomonas mobilis tRNA-guanine transglycosylase: replacement of protein-ligand hydrogen bonding by importing water clusters.
    Barandun LJ; Immekus F; Kohler PC; Tonazzi S; Wagner B; Wendelspiess S; Ritschel T; Heine A; Kansy M; Klebe G; Diederich F
    Chemistry; 2012 Jul; 18(30):9246-57. PubMed ID: 22736391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity inhibitors of Zymomonas mobilis tRNA-guanine transglycosylase through convergent optimization.
    Barandun LJ; Immekus F; Kohler PC; Ritschel T; Heine A; Orlando P; Klebe G; Diederich F
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1798-807. PubMed ID: 23999303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.
    Ritschel T; Hoertner S; Heine A; Diederich F; Klebe G
    Chembiochem; 2009 Mar; 10(4):716-27. PubMed ID: 19199329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexible adaptations in the structure of the tRNA-modifying enzyme tRNA-guanine transglycosylase and their implications for substrate selectivity, reaction mechanism and structure-based drug design.
    Brenk R; Stubbs MT; Heine A; Reuter K; Klebe G
    Chembiochem; 2003 Oct; 4(10):1066-77. PubMed ID: 14523925
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Nguyen A; Gemmecker G; Softley CA; Movsisyan LD; Pfaffeneder T; Heine A; Reuter K; Diederich F; Sattler M; Klebe G
    ACS Chem Biol; 2022 Jul; 17(7):1745-1755. PubMed ID: 35763700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase.
    Ritschel T; Kohler PC; Neudert G; Heine A; Diederich F; Klebe G
    ChemMedChem; 2009 Dec; 4(12):2012-23. PubMed ID: 19894214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis and crystallographic studies of Zymomonas mobilis tRNA-guanine transglycosylase reveal aspartate 102 as the active site nucleophile.
    Romier C; Reuter K; Suck D; Ficner R
    Biochemistry; 1996 Dec; 35(49):15734-9. PubMed ID: 8961936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening.
    Brenk R; Meyer EA; Reuter K; Stubbs MT; Garcia GA; Diederich F; Klebe G
    J Mol Biol; 2004 Apr; 338(1):55-75. PubMed ID: 15050823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase.
    Grädler U; Gerber HD; Goodenough-Lashua DM; Garcia GA; Ficner R; Reuter K; Stubbs MT; Klebe G
    J Mol Biol; 2001 Feb; 306(3):455-67. PubMed ID: 11178905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of specificity determinants in bacterial tRNA-guanine transglycosylase reveals queuine, the substrate of its eucaryotic counterpart, as inhibitor.
    Biela I; Tidten-Luksch N; Immekus F; Glinca S; Nguyen TX; Gerber HD; Heine A; Klebe G; Reuter K
    PLoS One; 2013; 8(5):e64240. PubMed ID: 23704982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of aspartic acid 143 in E. coli tRNA-guanine transglycosylase: insights from mutagenesis studies and computational modeling.
    Todorov KA; Tan XJ; Nonekowski ST; Garcia GA; Carlson HA
    Biophys J; 2005 Sep; 89(3):1965-77. PubMed ID: 15951383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of water molecules in a phosphate binding site by furanoside-appended lin-benzoguanine ligands of tRNA-guanine transglycosylase (TGT).
    Barandun LJ; Ehrmann FR; Zimmerli D; Immekus F; Giroud M; Grünenfelder C; Schweizer WB; Bernet B; Betz M; Heine A; Klebe G; Diederich F
    Chemistry; 2015 Jan; 21(1):126-35. PubMed ID: 25483606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.